Mitomycin derivatives having anti-tumor and antibacterial utilit

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

548422, A61K 3140, C07D48714

Patent

active

047710683

ABSTRACT:
Mitomycin derivatives of the formula: ##STR1## wherein X is ##STR2## [wherein R.sub.3 is alkyl, cycloalkyl or optionally substituted phenyl; and R.sub.4 is alkyl or cycloalkyl]; n is an integer of 2 to 8; one of R.sub.1 and R.sub.2 is a hydrogen atom and the other is a carbamoyloxymethyl group, or alternatively R.sub.1 and R.sub.2 may be combined together to form a methylene group (.dbd.CH.sub.2); and Y and Z independently represent hydrogen or methyl;
exhibit anti-bacterial and anti-tumor activities.

REFERENCES:
patent: 3332944 (1967-07-01), Cosulich et al.
patent: 4268676 (1981-05-01), Remers
patent: 4567256 (1986-01-01), Vyas et al.
patent: 4617389 (1986-10-01), Remers
Iyengar et al., Chem. Abstracts, vol. 98 (1983), entry 16475t.
The Merck Index, Tenth Ed., 1983-pp. 890, 891 and 1097.
The Journal of Antibiotics, vol. XXI, No. 3, Mar. 1968, pp. 189-198.
J. Med. Chem. 1983, vol. 26, No. 1, pp. 16-20.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Mitomycin derivatives having anti-tumor and antibacterial utilit does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mitomycin derivatives having anti-tumor and antibacterial utilit, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mitomycin derivatives having anti-tumor and antibacterial utilit will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-807229

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.